Jim Cramer on Boeing, Etsy, Moderna, Rivian, Royal Caribbean, Southwest

Boeing : The aircraft maker changed leadership of its embattled 737 Max program. “Doesn’t matter. Boeing, the leadership from the top is the only leadership government cares about,” Jim Cramer said Thursday. Dow stock Boeing was down slightly. Etsy : Shares of the online marketplace for handmade goods dropped 8% on an earnings miss and … Read more

Stock market today: Live updates

Manufacturing PMI exceeds economists’ expectations A purchasing managers index focused on the manufacturing industry came in higher than economists expected on Thursday. S&P Global’s flash U.S. manufacturing PMI climbed to 51.5 in February — a 17-month high from 50.7 the prior month. Economists polled by Dow Jones had anticipated the index would come in at … Read more

Moderna (MRNA) earnings Q4 2023

Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only marketable product.  The results cap a rocky year for the biotech company and other Covid vaccine makers, which all saw revenue plunge … Read more

GSK posts blowout RSV vaccine sales, raises outlook

Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020.  Dado Ruvic | Reuters GlaxoSmithKline on Wednesday lifted its long-term outlook following the smash-hit launch of its new RSV vaccine. The shot targeting the severe and in some cases life-threatening virus booked around £1.2 billion, or $1.5 billion, in … Read more

Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a … Read more

Merck, J&J CEOs agree to testify in Senate hearing on drug prices

US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | AFP | Getty Images The CEOs of Merck and … Read more

Treasury yields fractionally higher ahead of key data releases

U.S. Treasury yields nudged slightly higher on Tuesday morning, as market participants await the release of key economic data points later in the week. Near 2:25 a.m. ET, the yield on the benchmark 10-year Treasury note was around 1.7 basis points higher at 4.1109% while the yield on the 30-year Treasury bond was up just … Read more

Moderna Covid vaccine sales plunge in 2023, but meet company forecast

Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their sleeves for an updated version of the jab. The revenue from the shots met Moderna’s forecast for the year, even as sales plummeted from the … Read more

Jim Cramer reviews the worst performers on the Nasdaq-100 in 2023

CNBC’s Jim Cramer on Thursday gave his take on the worst performers in the Nasdaq-100 in 2023. Cramer compared each company’s closing price in 2022 to the end of 2023, noting the biggest losers. The list included healthcare companies as well as several utilities outfits. “You’ve heard of the Dogs of the Dow? Well, now … Read more

Moderna stock jumps after Oppenheimer upgrade on pipeline potential

Artur Widak | Nurphoto | Getty Images Shares of Moderna jumped more than 15% on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. The company’s stock has … Read more